Business
Hyperfine, Inc. Reports First Quarter 2026 Financial Results
GUILFORD, Conn., May 12, 2026--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced first quarter 2026 financial results and provided a business update.
About this update from Hyperfine, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":5227,"height":600,"url":"https://media.zenfs.com/en/business-wire.com/cc3c3b841e450cbeb8711279b708a339"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/JQg7xfnCckggFZvJWuz5aA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTExMA--/https://media.zenfs.com/en/business-wire.com/cc3c3b841e450cbeb8711279b708a339","width":960,"height":110},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/_tKc3blXpwoQNoXrDMc9kw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTcz/https://media.zenfs.com/en/business-wire.com/cc3c3b841e450cbeb8711279b708a339","width":640,"height":73},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/W3JxmyrBVtM1uVyadsBY4w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0yNzY-/https://media.zenfs.com/en/business-wire.com/cc3c3b841e450cbeb8711279b708a339","width":1200,"height":138}},"lazy":false},{"type":"text","content":"GUILFORD, Conn., May 12, 2026--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced first quarter 2026 financial results and provided a business update.","length":352,"tagName":"p"},{"type":"text","content":""Our execution in Q1 was strong. We delivered our second-highest revenue quarter to date with over 80% year-over-year revenue growth, driven by our accelerating commercial engine. We believe the international regulatory clearances we secured, the clinical data we released to the neurology and stroke communities, and the continued momentum in our office and hospital businesses all indicate portable brain MRI is becoming mainstream, and we are leading the charge," said Maria Sainz, Chief Executive Officer and President of Hyperfine, Inc.","length":551,"tagName":"p"},{"type":"text","content":"Recent Achievements and Business Highlights","length":43,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Obtained CE Marking and UK Conformity Assessment (UKCA) approval for both the next-generation Swoop® system and the latest Optive AI™ software in Europe.","length":153,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Enrolled first patient in Contrast PMR, a study d...